Crossmark

Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol 2017;71:952–60. Methodological Issues to Avoid Misinterpretation

Crossref DOI link: https://doi.org/10.1016/j.eururo.2017.06.007

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Giacalone, Nicholas J.

Niemierko, Andrzej

Shipley, William U.

Efstathiou, Jason A.
License Information

Text and Data Mining valid from 2017-09-01
More Information

This article is maintained by: Elsevier

Article Title: Reply to Saeid Safiri and Erfan Ayubi's Letter to the Editor re: Nicholas J. Giacalone, William U. Shipley, Rebecca H. Clayman, et al. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Eur Urol 2017;71:952–60. Methodological Issues to Avoid Misinterpretation

Journal Title: European Urology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eururo.2017.06.007

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eururo.2016.12.020

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eururo.2017.06.008

Content Type: simple-article

Copyright: © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below